Updated:
Nantahala Capital Management
Wil Harkey and Dan Mack run a market-neutral micro-cap equity strategy with over 19 years of track record at Nantahala Capital Management.
Nantahala Capital Management
Nantahala Capital Management was founded in 2004 and operates from New Canaan, Connecticut, with additional offices in Menlo Park, New York, Boston, Dallas, Herzeliya, and Zurich. Co-founders Wil Harkey and Dan Mack built the firm around a niche that most institutional managers structurally cannot access: small and micro-cap equities where low liquidity and thin sell-side coverage create persistent pricing gaps. The firm deploys a long/short equity strategy across a diversified portfolio, explicitly targeting companies with market capitalizations below $2.5 billion. The mandate is market-neutral — net equity exposure is managed to near zero, engineering a return stream with deliberately low correlation to US equity benchmarks. While the firm invests across sectors, its website specifically calls out a deep expertise in smaller healthcare companies, noting the space is 'in distress' and presenting wide, nonsensical valuation disparities. The strategy is long-duration by design; Nantahala describes its approach as a 'PE-style' partnership model, taking multi-year positions and working closely with portfolio companies rather than trading around quarterly events. The firm cites wider credit spreads and commercial real estate distress as tailwinds for its opportunity set in the current environment. Day-to-day portfolio construction sits with Harkey and Mack, who have a 19-plus-year track record in the micro-cap space. The firm maintains a lean operational footprint despite its seven-office geography, a footprint that suggests a capital-light structure optimized for research coverage rather than distribution. Nantahala does not publicly disclose assets under management, headcount, or individual position sizes. No adjacent philanthropic vehicles or co-investment club memberships are disclosed in its public materials. Nantahala's structural differentiator is its capacity discipline. The micro-cap strategy — by definition — excludes the vast majority of institutional capital that requires daily liquidity and mandates minimum market-cap floors. By pairing a long-term, low-turnover fundamental process with a market-neutral overlay, the firm occupies a hybrid space between a traditional long-biased small-cap manager and a quantitative market-neutral shop. This architecture makes it nearly impossible for a large allocator's core equity bucket to replicate, while the zero-beta posture keeps its returns legible to allocators measuring performance against absolute return hurdles rather than the Russell 2000.
General information
Firm type
Asset Manager
Year founded
2004
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New Canaan
Corporate office
130 Main Street, 2nd Floor, New Canaan, CT 06840, United States
Additional offices
Menlo Park · New York · Boston · Dallas · Herzeliya · Zurich
Principals
Wil Harkey
Portfolio Manager
Dan Mack
Portfolio Manager
Sector focus
Frequently asked questions
Who is responsible for investment decisions at Nantahala Capital Management?
Portfolio Managers Wil Harkey and Dan Mack share responsibility for the portfolio. The firm's website notes the two have worked together for over 16 years and have a combined track record exceeding 19 years in small and micro-cap investing. No other investment professionals are publicly named in a decision-making capacity.
How does Nantahala source ideas in a market most institutional managers ignore?
Nantahala focuses on a universe of companies below $2.5 billion in market capitalization — a segment many larger funds are structurally excluded from due to liquidity constraints and minimum position-size rules. The firm's long-term, partnership-oriented approach is designed to make it an attractive investor for micro-cap management teams, which can assist in proprietary origination. Its multi-office footprint across US and international cities may also support direct company engagement and research coverage in areas with sparse sell-side attention.
Is Nantahala a long-biased fund, or does it run short exposure?
Nantahala runs a long/short, market-neutral strategy. The firm explicitly states it targets 'little to no equity market exposure,' constructing a portfolio where long and short positions are designed to offset directional market risk. This means returns are driven by stock-specific alpha in both directions rather than broad equity market performance.
What makes Nantahala's approach to holding periods different from a typical small-cap hedge fund?
The firm applies what it calls a 'PE-style investment approach,' taking a multi-year view on its holdings. Rather than trading around earnings prints, Nantahala seeks to partner with portfolio companies for extended periods. This long-duration posture is well-suited to micro-cap names where entry and exit can take months to execute without moving prices and where underlying business transformations unfold over years, not quarters.
Which sector does Nantahala highlight as a specific area of expertise?
Nantahala's public materials specifically call out smaller healthcare companies, describing the sector as 'in distress' and presenting what the firm views as extremely wide and nonsensical valuation disparities. While the strategy is not exclusive to healthcare, the firm signals it as an area where its research depth and long-term horizon are particularly relevant given the complexity and binary-outcome risk common in micro-cap biotech and medical-device names.
Does Nantahala disclose its assets under management or team size?
No. The firm does not publish AUM figures or headcount numbers on its website. This non-disclosure is notable in a peer set where many small-cap managers use publicly stated growth as a marketing signal and may reflect a deliberate effort to avoid attracting attention to its capacity, which is inherently limited in the micro-cap space.
What is Nantahala's structural edge versus a larger multi-strategy platform running a small-cap sleeve?
Capacity is the primary structural edge. A multi-billion-dollar multi-strat firm cannot meaningfully allocate to sub-$2.5 billion companies without rapid position-size constraints and unintended beta. Nantahala is built exclusively for this end of the market, meaning its entire research process, trade-construction framework, and partnership-development approach are purpose-built for an opportunity set that larger peers can only dip into opportunistically, if at all.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: